These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32883584)

  • 1. Coronary Intravascular Brachytherapy for Recurrent Coronary Drug-Eluting Stent In-Stent Restenosis: A Systematic Review and Meta-Analysis.
    Megaly M; Glogoza M; Xenogiannis I; Vemmou E; Nikolakopoulos I; Omer M; Saad M; Willson L; Monyak DJ; Sullivan P; Pershad A; Chavez I; Mooney M; Traverse J; Wang Y; Garcia S; Poulose A; Burke MN; Brilakis ES
    Cardiovasc Revasc Med; 2021 Feb; 23():28-35. PubMed ID: 32883584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis.
    Varghese MJ; Bhatheja S; Baber U; Kezbor S; Chincholi A; Chamaria S; Buckstein M; Bakst R; Kini A; Sharma S
    Circ Cardiovasc Interv; 2018 Oct; 11(10):e006832. PubMed ID: 30354630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular brachytherapy versus drug-eluting stents in the treatment of in-stent restenosis: A meta-analysis of long-term outcomes.
    Benjo A; Cardoso RN; Collins T; Garcia D; Macedo FY; El-Hayek G; Nadkarni G; Aziz E; Jenkins JS
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):200-8. PubMed ID: 25963829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes With Combined Laser Atherectomy and Intravascular Brachytherapy in Recurrent Drug-Eluting Stent In-Stent Restenosis.
    Megaly M; Glogoza M; Xenogiannis I; Vemmou E; Nikolakopoulos I; Omer M; Willson L; Monyak DJ; Sullivan P; Stanberry L; Chavez I; Mooney M; Traverse J; Wang Y; Garcia S; Poulose A; Burke MN; Brilakis ES
    Cardiovasc Revasc Med; 2021 Jan; 22():29-33. PubMed ID: 32571761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure patterns after intravascular brachytherapy for in-stent coronary restenosis.
    Wallner K; Kearney KE; Kim M; Tiwana J; Elison D; Kim EY; Parvathaneni U; Lombardi WL; Phillips ML; Don C
    Catheter Cardiovasc Interv; 2022 Nov; 100(5):759-762. PubMed ID: 36098336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of brachytherapy treatment for coronary in-stent restenosis: Ten-year follow-up.
    Nakahama H; Jankowski M; Dixon SR; Abbas AE
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):E211-E216. PubMed ID: 30280480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of intravascular brachytherapy for recurrent drug-eluting in-stent restenosis.
    Megaly M; Glogoza M; Xenogiannis I; Vemmou E; Nikolakopoulos I; Willson L; Monyak DJ; Sullivan P; Stanberry L; Sorajja P; Chavez I; Mooney M; Traverse J; Wang Y; Garcia S; Poulose A; Burke MN; Brilakis ES
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):32-38. PubMed ID: 31943747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary Brachytherapy for Recurrent Drug-Eluting Stent Failure.
    Negi SI; Torguson R; Gai J; Kiramijyan S; Koifman E; Chan R; Randolph P; Pichard A; Satler LF; Waksman R
    JACC Cardiovasc Interv; 2016 Jun; 9(12):1259-1265. PubMed ID: 27339842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
    Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
    Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
    Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ;
    JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Northwell intracoronary brachytherapy for the treatment of recurrent drug eluting stent in-stent restenosis (NITDI study group).
    Meraj PM; Patel K; Patel A; Doshi R; Srinivas G; Jauhar R; Kaplan B; Garzon R; Sharma A; Cao Y; Diaz Molina F; Sharma R
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):41-46. PubMed ID: 31930652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of intravascular ultrasound on Outcomes following PErcutaneous coronary interventioN for In-stent Restenosis (iOPEN-ISR study).
    Shlofmitz E; Torguson R; Zhang C; Mintz GS; Dheendsa A; Khalid N; Chen Y; Musallam A; Rogers T; Hashim H; Ben-Dor I; Garcia-Garcia HM; Waksman R
    Int J Cardiol; 2021 Oct; 340():17-21. PubMed ID: 34371029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review.
    Xi Y; Chen J; Bi Y; Xie S; Liao T; Zhang Y; Kislauskis E; Wu T; Laham R; Xiao J
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E129-E141. PubMed ID: 31714010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
    Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
    Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Eluting Stent Restenosis: Modern Approach to a Classic Challenge.
    Donisan T; Madanat L; Balanescu DV; Mertens A; Dixon S
    Curr Cardiol Rev; 2023; 19(3):e030123212355. PubMed ID: 36597603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
    Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
    Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
    EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.